• AMSTERDAM
  • BRUSSELS
  • DÜSSELDORF
  • LYON
  • MADRID
  • MANNHEIM
  • MUNICH
  • PARIS

Press

Victory for PMI - General Court orders EUIPO Board of Appeals to rule again

5 February 2018
Mon, 02/05/2018 (All day)

On 1 February 2018, the General Court rendered a judgment in case T-105/16 cancelling a decision by the EUIPO’s Board of Appeals in invalidity proceedings initiated by Philip Morris (hereinafter, PMI), and ordering the Board of the EUIPO to rule again on the conflict. The Court ordered the Board to take into full account the probative value of the evidence that the latter had previously disregarded with the argument that it had been submitted for the first time during appeal proceedings and was consequently inadmissible. The Court ruled that article 76 EUTMR and Rule 50(2) EUTMIR do not allow for late evidence when it is not supplementary, but admitted the appeal based on the application of general principles of the law and, in particular, sound administration. The Court considered that there were sufficient grounds for an exception to the applicable legal provisions of the EUTMR and the EUTMIR in this case. The EUIPO and the intervener were ordered to bear the costs. This decision is welcome news after lengthy proceedings that began several years ago.

Laura Alonso and Alicia Martín of the Madrid office have represented Philip Morris since the filing of the appeal before the EUIPO Board of Appeals and before the General Court.
The judgment can be found here: http://bit.ly/2DZGjFk

  • A new edition of the Mobile World Congress (MWC), the world’s most important event in the mobile communications industry, will be held in Barcelona from 26th to 28th of February, 2019. The Commercial Courts of Barcelona have issued for the fifth consecutive year the Intellectual Property Fast Action Protocol in the framework of the Mobile World Congress.
  • The Brussels office of HOYNG ROKH MONEGIER is pleased to be one of the founding members of the Legal Diversity & Inclusion Alliance (LDIA), a collective effort by several law firms in Belgium.
  • On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings.
  • In the landmark Philips Nokia judgement of 1 December 2011 (joined cases C 446/09 and C 495/09) the CJEU responded to a referral by the Antwerp Court of First Instance that in the context of an infringement action it is up to the holder of the intellectual property right to demonstrate that the allegedly infringing goods are intended to be put on sale in the European Union.
  • The EUIPO has released its long awaited “Study on legislative measures related to online IPR infringements”, Carina Gommers and Stephanie Hermoye drafted the Belgian submission on civil measures.